FDA Direct: Combating Rare Diseases at the FDA

FDA Direct: кто покупает спин — крючок, леску и грузило?

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

FDA Direct: Combating Rare Diseases at the FDA

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

FDA Direct: эти 9 препаратов получили национальные приоритетные ваучеры

FDA’s Rare Disease Day 2026 – An Event for Patients

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces

FDA-USP-AAM | D1S4 – Q&A Discussion Panel

FDA-USP-AAM | D1S2 – Strengthening Your Compendial Strategy

FDA-USP-AAM | D1S1 – FDA's Participation in USP-NF Revision Process – Challenges and Solutions

Roundtable on PMTA Submissions for ENDS Products

2025 FDA Achievements

FDA Celebrates 120 Years